It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
COX-2 inhibitors in the treatment of cardiovascular disease.
https://arctichealth.org/en/permalink/ahliterature188083
Source
CMAJ. 2002 Oct 1;167(7):738-9; author reply 739-40
Publication Type
Article
Date
Oct-1-2002
More detail
Author
John C Peterson
Source
CMAJ. 2002 Oct 1;167(7):738-9; author reply 739-40
Date
Oct-1-2002
Language
English
Publication Type
Article
Keywords
Adverse Drug Reaction Reporting Systems
Canada
Cardiovascular Diseases - drug therapy - enzymology
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors - adverse effects
Humans
Isoenzymes - antagonists & inhibitors
Membrane Proteins
Prostaglandin-Endoperoxide Synthases
Notes
Cites: JAMA. 2000 Sep 13;284(10):1247-5510979111
Cites: N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 152811087881
Cites: Am J Ther. 2001 Mar-Apr;8(2):85-9511304662
Cites: JAMA. 2001 Aug 22-29;286(8):954-911509060
Cites: Am J Cardiol. 2002 Feb 15;89(4):425-3011835924
Cites: JAMA. 2001 Dec 12;286(22):2809-10; author reply 2811-211735745
Cites: JAMA. 2001 Dec 12;286(22):2810-1; author reply 2811-211735748
Cites: JAMA. 2001 Dec 12;286(22):2811-211735749
Cites: Clin Ther. 2001 Sep;23(9):1478-9111589261
PubMed ID
12389824
View in PubMed
Less detail
Permalink